RID Trademark

Trademark Overview

On Monday, August 24, 1998, a trademark application was filed for RID with the United States Patent and Trademark Office. The USPTO has given the RID trademark a serial number of 75540877. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, September 25, 2019. This trademark is owned by Pfizer Inc.. The RID trademark is filed in the Pharmaceutical Products category with the following description:

pediculicide pharmaceutical preparation
rid

General Information

Serial Number75540877
Word MarkRID
Filing DateMonday, August 24, 1998
Status800 - REGISTERED AND RENEWED
Status DateWednesday, September 25, 2019
Registration Number2276127
Registration DateTuesday, September 7, 1999
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 15, 1999

Trademark Statements

Goods and Servicespediculicide pharmaceutical preparation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 28, 1998
Primary Code005
First Use Anywhere DateMonday, November 10, 1975
First Use In Commerce DateMonday, November 10, 1975

Trademark Owner History

Party NameOYSTERSHELL CONSUMER HEALTH, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWAYNE, PA 19087
Party NameBAYER HEALTHCARE LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWhippany, NJ 07981
Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 28, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 28, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 25, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, September 25, 2019REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Wednesday, September 25, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 25, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 16, 2019TEAS SECTION 8 & 9 RECEIVED
Friday, September 7, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, March 13, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 13, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 25, 2009REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 25, 2009REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, September 10, 2009ASSIGNED TO PARALEGAL
Wednesday, September 2, 2009TEAS SECTION 8 & 9 RECEIVED
Wednesday, September 6, 2006CASE FILE IN TICRS
Tuesday, February 8, 2005REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, January 31, 2005REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, January 31, 2005TEAS SECTION 8 & 15 RECEIVED
Friday, April 19, 2002TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 7, 1999REGISTERED-PRINCIPAL REGISTER
Tuesday, June 15, 1999PUBLISHED FOR OPPOSITION
Friday, May 14, 1999NOTICE OF PUBLICATION
Tuesday, March 16, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 3, 1999ASSIGNED TO EXAMINER
Wednesday, March 3, 1999PETITION TO DIRECTOR - GRANTED
Monday, November 9, 1998PETITION TO DIRECTOR RECEIVED

Related Keywords

preparation pharmaceutical pediculicide